Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson daily Stock Chart
Johnson & Johnson
IndexDJIA S&P500 P/E25.91 EPS (ttm)5.48 Insider Own0.07% Shs Outstand2.69B Perf Week1.49%
Market Cap381.99B Forward P/E16.53 EPS next Y8.59 Insider Trans-1.90% Shs Float2.68B Perf Month4.90%
Income14.97B PEG3.35 EPS next Q2.03 Inst Own68.50% Short Float0.45% Perf Quarter16.90%
Sales80.68B P/S4.73 EPS this Y-8.50% Inst Trans0.79% Short Ratio1.99 Perf Half Y11.46%
Book/sh23.45 P/B6.05 EPS next Y5.46% ROA0.90% Target Price143.35 Perf Year6.58%
Cash/sh6.74 P/C21.06 EPS next 5Y7.73% ROE2.10% 52W Range118.62 - 148.32 Perf YTD1.62%
Dividend3.60 P/FCF41.01 EPS past 5Y7.10% ROI15.70% 52W High-4.27% Beta0.68
Dividend %2.54% Quick Ratio1.30 Sales past 5Y2.60% Gross Margin65.80% 52W Low19.69% ATR1.53
Employees134000 Current Ratio1.70 Sales Q/Q10.60% Oper. Margin22.10% RSI (14)76.53 Volatility0.87% 1.04%
OptionableYes Debt/Eq0.51 EPS Q/Q4.10% Profit Margin1.70% Rel Volume0.80 Prev Close140.46
ShortableYes LT Debt/Eq0.47 EarningsOct 16 BMO Payout572.60% Avg Volume6.11M Price141.98
Recom2.30 SMA203.69% SMA506.84% SMA2007.97% Volume5,019,257 Change1.08%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Sep-20-18 06:34PM  'We're ahead of the pack' in the cannabinoid drug space, says CEO of synthetic drugmaker Corbus CNBC
03:19PM  7 Dow Jones Stocks Leading the Push to New Highs InvestorPlace
01:43PM  Heres a clear case for owning dividend stocks instead of bonds MarketWatch
09:25AM  Lake Nona appears set to land big biotech facility American City Business Journals
Sep-19-18 04:57PM  Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results PR Newswire
11:05AM  J&J Files NDA for Erdafitinib in Urothelial Cancer Indication Zacks
08:47AM  The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering Benzinga
Sep-18-18 02:57PM  Health care ETF surges toward record in a broad sector rally MarketWatch
03:43AM  Exclusive - India, U.S. closing in on package deal to remove trade irritants Reuters
02:09AM  Cronos Gets Bigger As It Partners With Ginkgo Bioworks InvestorPlace
Sep-17-18 06:30PM  Glaxo Seeks EU Approval for Two-Drug Regimen in First-Line HIV Zacks
06:27PM  Pfizer's Skin Disease Candidates Positive in Mid-Stage Study Zacks
02:32PM  J&J Talc Supplier Takes No Chances on Another Big Jury Loss Bloomberg
10:10AM  Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again Zacks
08:19AM  Is Artificial Intelligence the Next Big Thing in Biotech? Zacks
Sep-14-18 03:55PM  Pacira Shares Look Expensive, Stifel Says In Bearish Initiation Benzinga
09:43AM  Pharma/Biotech Stocks to Watch This Prostate Cancer Month Zacks
Sep-13-18 03:35PM  5 Dow Jones Stocks That Are Gaining New Ground InvestorPlace
11:29AM  City of Boston sues drugmakers over opioid epidemic American City Business Journals
07:42AM  These 13 Stocks Have Raised Their Dividends for 50 Straight Years Motley Fool
Sep-12-18 10:27AM  Geron Corp: Lost in Translation? Motley Fool
Sep-11-18 02:33PM  12 Top Stock Picks to Shield Your Portfolio Kiplinger
10:00AM  Geron Corporation: A Sober Assessment Motley Fool
Sep-10-18 05:00PM  Shire's ADHD Portfolio Remains Strong Amid Competition Zacks
12:17PM  The Week Ahead: Apple's Special Event, Mobile World Congress, US Inflation Data On Deck Benzinga
09:36AM  Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod Zacks
08:04AM  The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Merck, Pfizer and Johnson & Johnson Zacks
Sep-07-18 10:41AM  Pharma Stock Roundup: NVS' Sandoz Deal, Pipeline Updates at AZN & Others in Focus Zacks
08:58AM  Lilly, Teva, Pfizer & Others Await FDA Decisions in September Zacks
08:00AM  How Tesaro Hopes to Tackle Lung Cancer Motley Fool
06:32AM  J&J to work with India on compensation for recalled hip implants Reuters
Sep-06-18 09:57AM  Large Cap Pharma Stocks Staging a Comeback in Second Half Zacks
Sep-05-18 06:07PM  J&J Submits NDA to the FDA for Depression Drug in Adults Zacks
02:35PM  9 Best Dividend Stocks to Buy for Every Investor InvestorPlace
09:23AM  3 Biotech Stocks That Still Have Major Catalysts in September Motley Fool
06:03AM  3 Dividend Stocks Perfect for Retirees Motley Fool
06:00AM  3 Top Stocks Under $10 Motley Fool
Sep-04-18 10:33AM  Geron Stock Up More Than 200% in 2018 So Far: Here's Why Zacks
Sep-03-18 09:31AM  In Your 40s? 3 Stocks You Might Want to Buy Motley Fool
Sep-02-18 05:49PM  Why Geron Corp. Soared 59.6% in August Motley Fool
11:41AM  3 Industries Looking to Partner With Marijuana Stocks Motley Fool
09:10AM  3 Biotech Stocks That Could Soar Next Week Motley Fool
Aug-31-18 11:56AM  [$$] Johnson & Johnson Heads Health Care List in Management Top 250 The Wall Street Journal
10:19AM  Pharma Stock Roundup: Approval of NVS & ABBV Cancer Drugs, MRK's HIV Drug in Focus Zacks
07:40AM  From Unilever to Ford, companies in Venezuela cling on by cutting products Reuters
Aug-30-18 11:36AM  Why K2M Group Holdings, Inc. Acquired a Higher Price Today Motley Fool
06:32AM  Better Buy: Johnson & Johnson vs. Merck Motley Fool
Aug-29-18 11:13PM  Morning News Call - India, August 30 Reuters
12:44PM  What Is Implied Volatility And Why Should Investors Care About It? InvestorPlace
09:00AM  Active Traders Remain Bullish on Healthcare Investopedia
07:30AM  [$$] Portola Pharmaceuticals Director Scores With Stock Purchase
03:14AM  Indian panel wants Johnson & Johnson to pay compensation over recalled implants Reuters
12:00AM  Ketamine is becoming a popular treatment for depression, but it acts like an opioid, study suggests CNBC
Aug-28-18 07:00PM  New Rules for This Market: Cramer's 'Mad Money' Recap (Tues. 8/28/18)
06:40PM  3 ETFs for Johnson & Johnson's Healthy Breakout Investopedia
05:30PM  Bayer's Blood Thinner Xarelto Fails in Line Extension Studies Zacks
04:30PM  Why Yum China Holdings, Brooks Automation, and Geron Jumped Today Motley Fool
01:29PM  25 Dividend Stocks That Analysts Love the Most Kiplinger
12:56PM  Why Geron Corporation's Stock Is Charging Higher Today Motley Fool
10:42AM  AbbVie's Imbruvica Combo Gets FDA Nod for Rare Lymphoma Zacks
09:29AM  Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron Motley Fool
12:00AM  [$$] Big pharma takes a gamble on NHS experiment Financial Times
Aug-27-18 02:56PM  UPDATE: Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business PR Newswire
11:52AM  Wall Street's latest bull run: The Greater Philadelphia public companies driving the rising tide American City Business Journals
11:19AM  This Company Proves That Thinking Small Can Pay Off Big Motley Fool
11:00AM  Has Geron Corporation's Stock Been De-Risked? Motley Fool
10:31AM  Sympathy Move: Portola Upgraded After Competitor Reports Sour Data Benzinga
09:59AM  Johnson & Johnson to Participate in the 2018 Morgan Stanley 16th Annual Global Healthcare Conference PR Newswire
08:30AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Nike, BP, eBay and BCE Zacks
07:40AM  Stocks making the biggest move premarket: TSLA, UAL, TWTR, NFLX & more CNBC
06:00AM  Johnson & Johnson May Rise 9% on Better Growth Investopedia
05:32AM  Johnson & Johnson to Host Investor Conference Call on the Phase 3 MARINER and COMMANDER HF Studies for XARELTO® PR Newswire
05:00AM  Bayer, J&J's bid to further widen use of Xarelto hits snag Reuters
Aug-26-18 07:15PM  3 Small-Cap Healthcare Stocks for Your Watch List Motley Fool
06:01AM  Better Buy: Intuitive Surgical, Inc. vs. Johnson & Johnson Motley Fool
Aug-24-18 11:32AM  Top Research Reports for Johnson & Johnson, NIKE & BP Zacks
08:18AM  3 Big Drug Stocks With Big Cash Stockpiles: Should You Spend Your Cash Buying Them? Motley Fool
Aug-23-18 03:42PM  Will Johnson & Johnson (NYSE:JNJ) Continue To Underperform Its Industry? Simply Wall St.
11:14AM  Caldwell Cassady & Curry Helps Acantha Win $8.2 Million Patent Infringement Verdict Against Medical Device Giant DePuy Synthes PR Newswire
10:04AM  J&J to Appeal as Judge Confirms Jury Order in Talc Case Zacks
07:52AM  Large-Cap Pharma Rebounds: 2 Stocks to Boost Your Portfolio Zacks
Aug-22-18 07:01PM  Jim Cramer: What Does Politics Have to Do With Johnson & Johnson's P/E?
06:23PM  Cramer: Michael Cohen plea and Paul Manafort verdict could have mixed effects on the market CNBC
03:05PM  Missouri judge affirms $4.69 billion talc verdict, J&J vows to appeal Reuters
02:58PM  Missouri judge affirms $4.69 billion talc verdict, Johnson & Johnson vows to appeal Reuters
Aug-21-18 07:25PM  Cramer: Drug stocks' rally doesn't mean a recession is on... CNBC Videos
07:01PM  Jim Cramer: This Is a Rotation, Not a Recession
03:38PM  5 Top Stock Trades for Wednesday How to Trade Kohls Earnings Rally InvestorPlace
12:53PM  J&J Stock Is Firming Up Nicely, Stay Long
12:11PM  JNJ Is Firming Up Nicely, Stay Long and Raise Stop Protection
Aug-20-18 04:54PM  MARKETS: Stocks rally but face headline risk in both directions Yahoo Finance Video
02:59PM  St. Charles County lawsuit accuses drug companies, distributors of worsening opioid epidemic American City Business Journals
02:37PM  5 Execs Talk Business Models At Cannabis Capital Conference Benzinga
10:33AM  What You Must Know About Johnson & Johnsons (NYSE:JNJ) Financial Strength Simply Wall St.
10:20AM  5 Hot Stocks in the Dow ETF Last Week Zacks
10:19AM  Johnson & Johnson to Host Investor Conference Call on the Pharmaceutical Business PR Newswire
Aug-19-18 12:07PM  Barron's Picks And Pans: AT&T, Starbucks, State Street, Verizon And More Benzinga
Aug-17-18 02:48PM  The Top UPS Shareholders (UPS) Investopedia
09:49AM  4 Mega-Cap Stocks to Buy As Theyre Thrust Into the Spotlight InvestorPlace
09:34AM  Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM